Rosetta Genomics Ltd. (ROSGQ)

Rosetta Genomics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Feb 21, 2025	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Market Capitalization	0	9	22	26	29	42
Market Cap Growth	-76.70%	-58.74%	-15.56%	-7.65%	-31.92%	2354.64%
Enterprise Value	3	3	13	7	-0	36
Last Close Price	0.00	5.04	14.76	27.12	35.04	55.56
PS Ratio	0.00	4.52	7.78	19.95	70.80	209.54
PB Ratio	0.00	2.09	1.14	1.76	1.21	1.36
P/TBV Ratio	5.08	2.09	1.14	1.76	1.21	1.36
EV/Sales Ratio	1.10	1.63	4.43	5.09	-	178.07
Debt / Equity Ratio	2.23	0.86	-	-	-	-
Asset Turnover	0.26	0.12	0.14	0.06	0.01	0.01
Quick Ratio	0.85	1.31	4.90	7.29	12.80	24.64
Current Ratio	2.09	2.50	6.91	7.44	12.90	25.08
Return on Equity (ROE)	-137.95%	-109.70%	-83.88%	-75.07%	-48.30%	-70.04%
Return on Assets (ROA)	-60.19%	-45.93%	-41.24%	-41.28%	-28.56%	-29.89%
Return on Capital (ROIC)	-81.02%	-56.75%	-47.21%	-46.04%	-30.59%	-33.80%
Earnings Yield	-2258010.12%	-175.98%	-77.58%	-54.86%	-44.98%	-24.83%
FCF Yield	-1977740.30%	-116.04%	-76.26%	-52.30%	-39.18%	-21.15%
Buyback Yield / Dilution	-34.34%	-46.51%	-34.28%	-17.16%	-115.67%	-776.33%
Total Shareholder Return	-34.34%	-46.51%	-34.28%	-17.16%	-115.67%	-776.33%

Source: S&P Capital IQ. Standard template. Financial Sources.